ZD9331
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for ZD9331, covering 2013-08-02 to 2013-08-02. Get the full timeline:
Most recent: Clinical Trial Update: ZD9331 With or Without Topotecan in Treating Patients With Refractory or Recurrent Epithelial Ovarian Cancer, Fallopian Tube Cancer, or Primary Peritoneal Cancer [Phase 2]